Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia affects mental health, causing depression and anxiety, but new treatments can improve both hair growth and quality of life.

Alopecia affects mental health, causing depression and anxiety, but new treatments can help improve both hair growth and quality of life.

HMPV causes respiratory infections, mainly managed with supportive care, and lacks a vaccine or specific treatment.

Irish dermatologists urgently need guidelines for using JAK inhibitors in treating alopecia areata.

Certain medications like antipsychotics and some antidepressants increase the risk of falls in older patients.

Vitiligo often starts young, is linked to family history and stress, and requires comprehensive care including psychological support.

Ritlecitinib provides new treatment options for diverse alopecia areata patients.

Patients with anxiety or depression report more severe alopecia areata.

"Burning scalp" syndrome causes discomfort and may be managed with special cosmetics.

Severe alopecia areata greatly impacts quality of life, mental health, and daily activities.

Patients with rheumatoid arthritis using tofacitinib had more serious side effects than those with alopecia areata.

Alopecia areata causes sudden hair loss, has genetic links, and can be managed but not cured.

Laparoscopic sleeve gastrectomy is safe and effective for treating obesity in children and teens.

Older people with severe COVID-19, especially those with certain health conditions, are more likely to experience post-COVID syndrome.

Periodontitis may increase the risk of developing alopecia areata.

An infant with complete hair loss was diagnosed with a genetic disorder affecting hair growth.

Post-COVID-19 patients often experience musculoskeletal issues, fitness decline, behavioral changes, chest pain, cough, hair loss, and nervous system problems.

Long COVID recovery is hindered by smoking, with hair loss being a difficult symptom to treat.

Type 3 acromegaly patients have more health issues and higher death risk.

Early diagnosis and treatment can prevent or delay frontal fibrosing alopecia progression in postmenopausal women.

Most patients with rheumatoid arthritis continued methotrexate treatment over two years, but those who stopped and restarted experienced more side effects and less improvement.

Polycystic Ovary Syndrome (PCOS) affects 6%-15% of women of reproductive age, causing symptoms like acne and hair loss, and increasing the risk of type 2 diabetes and heart disease; it's managed through diet, exercise, and medications like Metformin and hormonal contraceptives.

The book explains causes and treatments for common hair loss, its psychological effects, related health risks, and emphasizes early screening and lifestyle changes.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

Despite progress, better treatments and understanding are needed for the high rates of long-term issues and deaths linked to eating disorders.

Combining therapy, behavior techniques, and medication can help manage trichotillomania and depression.

PrEP doesn't increase STI risk in high-risk men, anti-androgen drugs may lower ICU admission for male COVID-19 patients, a 3-point injection is better for crow's feet, and the 'Geriatric-8' tool could help assess frailty in older skin cancer patients.

Insulin resistance and obesity are key factors in the development and worsening of polycystic ovary syndrome, and lifestyle changes are important for managing it.

People with alopecia areata are more likely to have other immune-related conditions.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.